Management of the Clinically Inapparent Adrenal Mass

  1. Glenn D. Braunstein, MD; and
  2. for the National Institutes of Health State-of-the Science Adrenal Incidentaloma Panel
  1. From Cedars-Sinai Medical Center, Los Angeles, CA 90048.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    IN RESPONSE:

    Dr. Copeland raises some good points. However, although several publications have appeared since our conference, high-quality data in …

    This 100-word excerpt has been provided in the absence of an abstract.

    « Previous | Next Article »Table of Contents